Children’s Cancer CoLab and Maddie Riewoldt’s Vision Clinician-Researcher Fellowship
Enable a clinician-researcher to accelerate breakthroughs at the intersection of Bone Marrow Failure Syndromes and paediatric oncology.
Enable a clinician-researcher to accelerate breakthroughs at the intersection of Bone Marrow Failure Syndromes and paediatric oncology.
Aim: Invest up to $250,000 to foster the next generation of clinical leaders who will improve outcomes for children and families affected by Bone Marrow Failure Syndromes and childhood cancer.
Genetic mutations affecting bone marrow can cause both rare cancers and Bone Marrow Failure Syndromes in children. These conditions can have devastating impacts on patients and their families.
In Australia, three children die every week from cancer, and one in five children diagnosed with cancer does not survive. Bone Marrow Failure Syndromes are diagnosed in up to 160 people annually, with children and young people making up most cases. Tragically, 50% of these patients will not survive.
The intricate relationship between Bone Marrow Failure Syndromes and paediatric oncology represents a critical intersection where collaborative research could make a difference for young patients.
Children’s Cancer CoLab and Maddie Riewoldt’s Vision have a united goal to improve outcomes for children and adolescents affected by these rare diseases. Through this partnership, the two organisations are committed to fostering emerging talent among clinician-researchers by supporting their career advancement and, in doing so, attracting and retaining the brightest minds in the field where Bone Marrow Failure Syndromes and paediatric oncology intersect.
The Children’s Cancer CoLab and Maddie Riewoldt’s Vision Clinician-Researcher Fellowship will support clinician-researchers who are committed to advancing research and clinical care in the intersection of Bone Marrow Failure Syndromes and paediatric oncology.
This fellowship will address one of the most critical challenges facing this specialised research today: the shortage of talent.
This talent shortage stems from persistent underfunding, limited resources, and a lack of targeted incentives, which are factors recognised as significant barriers to scientific and clinical progress. As a result, too few emerging professionals can build sustainable research careers or develop the expertise required to lead the breakthroughs of tomorrow in Bone Marrow Failure Syndromes and cancer development in children.
To help overcome these challenges, the fellowship provides a uniquely flexible model for clinicians seeking to develop their research capabilities. The program aims to give clinicians the foundational support, mentorship, and protected time needed to consolidate research skills and establish themselves as leaders in their fields.
This collaborative funding opportunity from Children’s Cancer CoLab and Maddie Riewoldt’s Vision is founded on a strong commitment to scientific quality. A special scientific advisory committee, bringing together subject matter experts from both organisations, defined the research priorities and designed the clinician-researcher model, ensuring this funding opportunity will bring a meaningful difference to the interdisciplinary field of Bone Marrow Failure Syndromes and paediatric oncology.
The fellowship aims to foster the next generation of clinical leaders who will improve outcomes for children and families affected by Bone Marrow Failure Syndromes and childhood cancer.
Funding available: Up to $250,000 for two years
Applications for the 2025-2026 funding round for the Children’s Cancer CoLab and Maddie Riewoldt’s Vision Clinician-Researcher Fellowship open on 8 September 2025 and close on 17 October 2025.
One clinician-researcher fellowship will be awarded.
Our program funding is allocated through a competitive process underpinned by robust expert review. We adopt scientific rigour to evaluate each proposal’s potential for impact and alignment with identified childhood cancer research and care priorities.
